Abstract
Rare variants in the many genes related to Notch signaling cause diverse Mendelian diseases that affect myriad organ systems. In addition, genome- and exome-wide association studies have linked common and rare variants in Notch-related genes to common diseases and phenotypic traits. Moreover, somatic mutations in these genes have been observed in many types of cancer, some of which are classified as oncogenic and others as tumor suppressive. While functional characterization of some of these variants has been performed through experimental studies, the number of “variants of unknown significance” identified in patients with diverse conditions keeps increasing as high-throughput sequencing technologies become more commonly used in the clinic. Furthermore, as disease gene discovery efforts identify rare variants in human genes that have yet to be linked to a disease, the demand for functional characterization of variants in these “genes of unknown significance” continues to increase. In this chapter, we describe a workflow to functionally characterize a rare variant in a Notch signaling related gene that was found to be associated with late-onset Alzheimer’s disease. This pipeline involves informatic analysis of the variant of interest using diverse human and model organism databases, followed by in vivo experiments in the fruit fly Drosophila melanogaster. The protocol described here can be used to study variants that affect amino acids that are not conserved between human and fly. By “humanizing” the almondex gene in Drosophila with mutant alleles and heterologous genomic rescue constructs, a missense variant in TM2D3 (TM2 Domain Containing 3) was shown to be functionally damaging. This, and similar approaches, greatly facilitate functional interpretations of genetic variants in the human genome and propel personalized medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kopan R, Ilagan MXG (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137:216–233
Ables JL, Breunig JJ, Eisch AJ et al (2011) Not(ch) just development: Notch signalling in the adult brain. Nat Rev Neurosci 12:269–283
Yamamoto S, Schulze KL, Bellen HJ (2014) Introduction to Notch signaling. Methods Mol Biol 1187:1–14
Artavanis-Tsakonas S, Muskavitch MAT (2010) Notch: the past, the present, and the future, Notch signaling. Elsevier, Amsterdam, pp 1–29
Greenwald I (2012) Notch and the awesome power of genetics. Genetics 191:655–669
Louvi A, Artavanis-Tsakonas S (2012) Notch and disease: a growing field. Semin Cell Dev Biol 23:473–480
Ho DM, Artavanis-Tsakonas S, Louvi A (2020) The Notch pathway in CNS homeostasis and neurodegeneration. Wiley interdisciplinary reviews. Dev Biol 9:e358
Mašek J, Andersson ER (2017) The developmental biology of genetic Notch disorders. Development 144:1743–1763
Salazar JL, Yamamoto S (2018) Integration of drosophila and human genetics to understand notch signaling related diseases. Adv Exp Med Biol 1066:141–185
Hassed S, Li S, Mulvihill J et al (2017) Adams-Oliver syndrome review of the literature: refining the diagnostic phenotype. Am J Med Genet A 173:790–800
Gilbert MA, Spinner NB (2017) Alagille syndrome: genetics and functional models. Curr Pathobiol Rep 5:233–241
Nóbrega A, Maia-Fernandes AC, Andrade RP (2021) Altered cogs of the clock: insights into the embryonic etiology of spondylocostal dysostosis. J Dev Biol 9
Mizuno T, Mizuta I, Watanabe-Hosomi A et al (2020) Clinical and genetic aspects of CADASIL. Front Aging Neurosci 12:91
Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 8:595–608
Splinter K, Adams DR, Bacino CA et al (2018) Effect of genetic diagnosis on patients with previously undiagnosed disease. N Engl J Med 379:2131–2139
Posey JE, O’Donnell-Luria AH, Chong JX et al (2019) Insights into genetics, human biology and disease gleaned from family based genomic studies. Genet Med 21:798–812
Fischer-Zirnsak B, Segebrecht L, Schubach M et al (2019) Haploinsufficiency of the notch ligand DLL1 causes variable neurodevelopmental disorders. Am J Hum Genet 105:631–639
Chong JX, Buckingham KJ, Jhangiani SN et al (2015) The genetic basis of mendelian phenotypes: discoveries, challenges, and opportunities. Am J Hum Genet 97:199–215
Simpson MA, Irving MD, Asilmaz E et al (2011) Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet 43:303–305
Isidor B, Lindenbaum P, Pichon O et al (2011) Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet 43:306–308
McDaniell R, Warthen DM, Sanchez-Lara PA et al (2006) NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the NOTCH signaling pathway. Am J Hum Genet 79:169–173
Gripp KW, Robbins KM, Sobreira NL et al (2015) Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndrome. Am J Med Genet A 167A:271–281
Martignetti JA, Tian L, Li D et al (2013) Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet 92:1001–1007
Stevens DL, Hewlett RH, Brownell B (1977) Chronic familial vascular encephalopathy. Lancet 1:1364–1365
Joutel A, Corpechot C, Ducros A et al (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710
Bamshad MJ, Nickerson DA, Chong JX (2019) Mendelian gene discovery: fast and furious with no end in sight. Am J Hum Genet 105:448–455
Baldridge D, Wangler MF, Bowman AN et al (2021) Model organisms contribute to diagnosis and discovery in the undiagnosed diseases network: current state and a future vision. Orphanet J Rare Dis 16:206
Wei J, Hemmings GP (2000) The NOTCH4 locus is associated with susceptibility to schizophrenia. Nat Genet 25:376–377
Qu J, Qu H-Q, Bradfield JP et al (2021) Association of DLL1 with type 1 diabetes in patients characterized by low polygenic risk score. Metab Clin Exp 114:154418
Kunkle BW, Grenier-Boley B, Sims R et al (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet 51:414–430
Patel D, Mez J, Vardarajan BN et al (2019) Association of rare coding mutations with alzheimer disease and other dementias among adults of European Ancestry. JAMA Netw Open 2:e191350
Pairo-Castineira E, Clohisey S, Klaric L et al (2021) Genetic mechanisms of critical illness in COVID-19. Nature 591:92–98
Jakobsdottir J, van der Lee SJ, Bis JC et al (2016) Rare functional variant in TM2D3 is associated with late-onset Alzheimer’s disease. PLoS Genet 12:e1006327
Zhou X, Li H, Guo S et al (2019) Associations of multiple NOTCH4 exonic variants with systemic sclerosis. J Rheumatol 46:184–189
All of Us Research Program Investigators, Denny JC, Rutter JL et al (2019) The “All of Us” Research Program. N Engl J Med 381:668–676
Lichou F, Trynka G (2020) Functional studies of GWAS variants are gaining momentum. Nat Commun 11:6283
Aster JC, Pear WS, Blacklow SC (2017) The varied roles of notch in cancer. Annu Rev Pathol 12:245–275
Lobry C, Oh P, Mansour MR et al (2014) Notch signaling: switching an oncogene to a tumor suppressor. Blood 123:2451–2459
Yamamoto S (2020) Making sense out of missense mutations: mechanistic dissection of Notch receptors through structure-function studies in Drosophila. Develop Growth Differ 62:15–34
Weng AP, Ferrando AA, Lee W et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269–271
Wang NJ, Sanborn Z, Arnett KL et al (2011) Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A 108:17761–17766
Katoh M, Katoh M (2020) Precision medicine for human cancers with Notch signaling dysregulation (review). Int J Mol Med 45:279–297
Ilagan MXG, Kopan R (2014) Monitoring Notch activation in cultured mammalian cells: transcriptional reporter assays. Methods Mol Biol 1187:143–154
Ilagan MXG, Kopan R (2014) Monitoring Notch activation in cultured mammalian cells: luciferase complementation imaging assays. Methods Mol Biol 1187:155–168
Serneels L, Tesseur I, De Strooper B (2014) Assay to probe proteolytic processing of Notch by γ-secretase. Methods Mol Biol 1187:223–229
Gridley T, Groves AK (2014) Overview of genetic tools and techniques to study Notch signaling in mice. Methods Mol Biol 1187:47–61
Marathe S, Alberi L (2014) Monitoring Notch activity in the mouse. Methods Mol Biol 1187:115–129
Justice MJ, Dhillon P (2016) Using the mouse to model human disease: increasing validity and reproducibility. Dis Model Mech 9:101–103
Clark JF, Dinsmore CJ, Soriano P (2020) A most formidable arsenal: genetic technologies for building a better mouse. Genes Dev 34:1256–1286
Wangler MF, Yamamoto S, Chao H-T et al (2017) Model organisms facilitate rare disease diagnosis and therapeutic research. Genetics 207:9–27
Boycott KM, Campeau PM, Howley HE et al (2020) The Canadian rare diseases models and mechanisms (RDMM) network: connecting understudied genes to model organisms. Am J Hum Genet 106:143–152
Bellen HJ, Yamamoto S (2015) Morgan’s legacy: fruit flies and the functional annotation of conserved genes. Cell 163:12–14
Venken KJT, Sarrion-Perdigones A, Vandeventer PJ et al (2016) Genome engineering: Drosophila melanogaster and beyond. Wiley interdisciplinary reviews. Dev Biol 5:233–267
Kanca O, Bellen HJ, Schnorrer F (2017) Gene tagging strategies to assess protein expression, localization, and function in drosophila. Genetics 207:389–412
Bellen HJ, Wangler MF, Yamamoto S (2019) The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases. Hum Mol Genet 28:R207–R214
Larkin A, Marygold SJ, Antonazzo G et al (2021) FlyBase: updates to the Drosophila melanogaster knowledge base. Nucleic Acids Res 49:D899–D907
Greenspan RJ (2004) Fly pushing: the theory and practice of drosophila genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Dahmann C (2018) Drosophila: methods and protocols. Springer, New York
Ashburn MD, Golic KG, Hawley RS (2005) Drosophila: a laboratory handbook. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Ghosh R, Oak N, Plon SE (2017) Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines. Genome Biol 18:225
Coban-Akdemir Z, White JJ, Song X et al (2018) Identifying genes whose mutant transcripts cause dominant disease traits by potential gain-of-function alleles. Am J Hum Genet 103:171–187
Katsonis P, Koire A, Wilson SJ et al (2014) Single nucleotide variations: biological impact and theoretical interpretation. Protein Sci 23:1650–1666
Muller HJ (1932) Further studies on the nature and causes of gene mutations. In: International congress on genetics, vol 6.1, pp 213–255
Manolio TA, Fowler DM, Starita LM et al (2017) Bedside back to bench: building bridges between basic and clinical genomic research. Cell 169:6–12
Sawyer SL, Hartley T, Dyment DA et al (2016) Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care. Clin Genet 89:275–284
Eldomery MK, Coban-Akdemir Z, Harel T et al (2017) Lessons learned from additional research analyses of unsolved clinical exome cases. Genome Med 9:26
Ma X, Shao Y, Tian L et al (2019) Analysis of error profiles in deep next-generation sequencing data. Genome Biol 20:50
Tam V, Patel N, Turcotte M et al (2019) Benefits and limitations of genome-wide association studies. Nat Rev Genet 20:467–484
Wang J, Al-Ouran R, Hu Y et al (2017) MARRVEL: integration of human and model organism genetic resources to facilitate functional annotation of the human genome. Am J Hum Genet 100:843–853
Karczewski KJ, Francioli LC, Tiao G et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434–443
Landrum MJ, Chitipiralla S, Brown GR et al (2020) ClinVar: improvements to accessing data. Nucleic Acids Res 48:D835–D844
Bragin E, Chatzimichali EA, Wright CF et al (2014) DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Res 42:D993–D1000
Rentzsch P, Witten D, Cooper GM et al (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47:D886–D894
Ioannidis NM, Rothstein JH, Pejaver V et al (2016) REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet 99:877–885
Amberger JS, Bocchini CA, Scott AF et al (2019) OMIM.org: leveraging knowledge across phenotype-gene relationships. Nucleic Acids Res 47:D1038–D1043
Wang J, Liu Z, Bellen HJ et al (2019) Navigating MARRVEL, a web-based tool that integrates human genomics and model organism genetics information. J Vis Exp (150). https://doi.org/10.3791/59542
Wang J, Mao D, Fazal F et al (2019) Using MARRVEL v1.2 for bioinformatics analysis of human genes and variant pathogenicity. Curr Protoc Bioinformatics 67:e85
Hu Y, Flockhart I, Vinayagam A et al (2011) An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics 12:357
Shefchek KA, Harris NL, Gargano M et al (2020) The Monarch Initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across species. Nucleic Acids Res 48:D704–D715
Alliance of Genome Resources Consortium (2020) Alliance of Genome Resources Portal: unified model organism research platform. Nucleic Acids Res 48:D650–D658
Hu Y, Comjean A, Mohr SE et al (2017) Gene2function: an integrated online resource for gene function discovery. G3 (Bethesda MD) 7:2855–2858
Harnish JM, Deal SL, Chao H-T et al (2019) In vivo functional study of disease-associated rare human variants using Drosophila. J Vis Exp (150). https://doi.org/10.3791/59658
Housden BE, Perrimon N (2016) Design and generation of donor constructs for genome engineering in Drosophila. Cold Spring Harbor Protoc (9). https://doi.org/10.1101/pdb.prot090787. https://pubmed.ncbi.nlm.nih.gov/27587780/
Li-Kroeger D, Kanca O, Lee P-T et al (2018) An expanded toolkit for gene tagging based on MiMIC and scarless CRISPR tagging in Drosophila. eLife 7:e38709
Psaty BM, O’Donnell CJ, Gudnason V et al (2009) Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2:73–80
Grove ML, Yu B, Cochran BJ et al (2013) Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One 8:e68095
Sims R, Hill M, Williams J (2020) The multiplex model of the genetics of Alzheimer’s disease. Nat Neurosci 23:311–322
Ebenesersdóttir SS, Sandoval-Velasco M, Gunnarsdóttir ED et al (2018) Ancient genomes from Iceland reveal the making of a human population. Science 360:1028–1032
Shannon MP (1972) Characterization of the female-sterile mutant almondex of Drosophila melanogaster. Genetica 43:244–256
Green MM, Green KC (1956) A cytogenetic analysis of the lozenge pseudoalleles in Drosophila. Zeitschrift fur induktive Abstammungs- und Vererbungslehre 87:708–721
Lehmann R, Jiménez F, Dietrich U et al (1983) On the phenotype and development of mutants of early neurogenesis inDrosophila melanogaster. Wilhelm Rouxs Arch Dev Biol 192:62–74
de-la-Concha A, Dietrich U, Weigel D et al (1988) Functional interactions of neurogenic genes of Drosophila melanogaster. Genetics 118:499–508
Michellod M-A, Forquignon F, Santamaria P et al (2003) Differential requirements for the neurogenic gene almondex during Drosophila melanogaster development. Genesis 37:113–122
Michellod M-A, Randsholt NB (2008) Implication of the Drosophila beta-amyloid peptide binding-like protein AMX in Notch signaling during early neurogenesis. Brain Res Bull 75:305–309
Sherrington R, Rogaev EI, Liang Y et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375:754–760
Rogaev EI, Sherrington R, Rogaeva EA et al (1995) Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376:775–778
McQuilton P, St Pierre SE, Thurmond J et al (2012) FlyBase 101--the basics of navigating FlyBase. Nucleic Acids Res 40:D706–D714
Gratz SJ, Cummings AM, Nguyen JN et al (2013) Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194:1029–1035
Bassett AR, Tibbit C, Ponting CP et al (2013) Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep 4:220–228
Yu Z, Ren M, Wang Z et al (2013) Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics 195:289–291
Kondo S, Ueda R (2013) Highly improved gene targeting by germline-specific Cas9 expression in Drosophila. Genetics 195:715–721
Kanca O, Andrews JC, Lee P-T et al (2019) De novo variants in WDR37 are associated with epilepsy, Colobomas, dysmorphism, developmental delay, intellectual disability, and cerebellar hypoplasia. Am J Hum Genet 105:413–424
Gratz SJ, Ukken FP, Rubinstein CD et al (2014) Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila. Genetics 196:961–971
Wiedenheft B, Sternberg SH, Doudna JA (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482:331–338
Housden BE, Valvezan AJ, Kelley C et al (2015) Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi. Sci Signal 8:rs9
Haelterman NA, Jiang L, Li Y et al (2014) Large-scale identification of chemically induced mutations in Drosophila melanogaster. Genome Res 24:1707–1718
Port F, Chen H-M, Lee T et al (2014) Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila. Proc Natl Acad Sci U S A 111:E2967–E2976
Engler C, Kandzia R, Marillonnet S (2008) A one pot, one step, precision cloning method with high throughput capability. PLoS One 3:e3647
Casini A, Storch M, Baldwin GS et al (2015) Bricks and blueprints: methods and standards for DNA assembly. Nat Rev Mol Cell Biol 16:568–576
Marillonnet S, Werner S (2015) Assembly of multigene constructs using golden gate cloning. Methods Mol Biol 1321:269–284
Marillonnet S, Grützner R (2020) Synthetic DNA assembly using golden gate cloning and the hierarchical modular cloning pipeline. Curr Protoc Mol Biol 130:e115
Mukherjee M, Caroll E, Wang ZQ (2021) Rapid assembly of multi-gene constructs using modular golden gate cloning. J Vis Exp (168). https://doi.org/10.3791/61993. https://pubmed.ncbi.nlm.nih.gov/33616121/
Gibson DG, Young L, Chuang R-Y et al (2009) Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6:343–345
Bachmann A, Knust E (2008) The use of P-element transposons to generate transgenic flies. Methods Mol Biol 420:61–77
Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401–415
Lee P-T, Zirin J, Kanca O et al (2018) A gene-specific T2A-GAL4 library for Drosophila. eLife 7:e35574
Feng S, Lu S, Grueber WB et al (2021) Scarless engineering of the Drosophila genome near any site-specific integration site. Genetics 217:iyab012
Venken KJT, Bellen HJ (2014) Chemical mutagens, transposons, and transgenes to interrogate gene function in Drosophila melanogaster. Methods 68:15–28
Bischof J, Björklund M, Furger E et al (2013) A versatile platform for creating a comprehensive UAS-ORFeome library in Drosophila. Development 140:2434–2442
Pirrotta V (1988) Vectors for P-mediated transformation in Drosophila. Biotechnology 10:437–456
Venken KJT, He Y, Hoskins RA et al (2006) P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science 314:1747–1751
Sarov M, Barz C, Jambor H et al (2016) A genome-wide resource for the analysis of protein localisation in Drosophila. eLife 5:e12068
Adams MD, Celniker SE, Holt RA et al (2000) The genome sequence of Drosophila melanogaster. Science 287:2185–2195
Venken KJT, Carlson JW, Schulze KL et al (2009) Versatile P[acman] BAC libraries for transgenesis studies in Drosophila melanogaster. Nat Methods 6:431–434
Salazar JL, Yang S.-A, Lin YQ et al (2021) Alzheimer’s disease-associated TM2D genes regulate Notch signaling and neuronal function in Drosophila. PLoS Genet 17:e1009962. https://doi.org/10.1371/journal.pgen.1009962. https://pubmed.ncbi.nlm.nih.gov/34905536/
Muskavitch MA (1994) Delta-notch signaling and Drosophila cell fate choice. Dev Biol 166:415–430
Lehmann R, Dietrich U, Jiménez F et al (1981) Mutations of early neurogenesis inDrosophila. Wilhelm Rouxs Arch Dev Biol 190:226–229
Acknowledgments
J.L.S. received support from the National Institutes of Health (NIH) training grant T32GM008307. S.Y. received support from the NIH (R01AG071557), Alzheimer’s Association (NIRH-15-364099), and Nancy Chang PhD, Award for Research Excellence from Baylor College of Medicine related to the project discussed in this article. We thank J. Michael Harnish for providing useful feedback.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Yang, SA., Salazar, J.L., Li-Kroeger, D., Yamamoto, S. (2022). Functional Studies of Genetic Variants Associated with Human Diseases in Notch Signaling-Related Genes Using Drosophila. In: Jia, D. (eds) Notch Signaling Research. Methods in Molecular Biology, vol 2472. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2201-8_19
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2201-8_19
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2200-1
Online ISBN: 978-1-0716-2201-8
eBook Packages: Springer Protocols